Search details
1.
Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38626801
2.
Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer.
J Natl Compr Canc Netw
; 21(4): 359-365.e4, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37015336
3.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37856213
4.
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
J Natl Compr Canc Netw
; 20(12): 1288-1298, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36509074
5.
Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer.
Prostate
; 81(4): 223-230, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33471385
6.
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
J Natl Compr Canc Netw
; 19(2): 134-143, 2021 02 02.
Article
in English
| MEDLINE | ID: mdl-33545689
7.
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(5): 479-505, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085757
8.
Prostate Cancer, Version 1.2016.
J Natl Compr Canc Netw
; 14(1): 19-30, 2016 01.
Article
in English
| MEDLINE | ID: mdl-26733552
9.
NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?
J Natl Compr Canc Netw
; 13(5 Suppl): 640-2, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25995417
10.
Prostate cancer, version 2.2014.
J Natl Compr Canc Netw
; 12(5): 686-718, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24812137
11.
Phase II Trial of Concurrent Nivolumab and Radiation Therapy for Muscle-Invasive Bladder Cancer of Older or Chemotherapy-Ineligible Patients.
Int J Radiat Oncol Biol Phys
; 118(5): 1472-1480, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-37981040
12.
The role of active surveillance in the management of prostate cancer.
J Natl Compr Canc Netw
; 11(2): 183-7, 2013 Feb 01.
Article
in English
| MEDLINE | ID: mdl-23411385
13.
Prostate cancer, version 1.2014.
J Natl Compr Canc Netw
; 11(12): 1471-9, 2013 Dec 01.
Article
in English
| MEDLINE | ID: mdl-24335682
14.
The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.
Urol Oncol
; 41(12): 483.e21-483.e26, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37945390
15.
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw
; 10(9): 1081-7, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22956807
16.
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.
Cancer
; 117(24): 5579-88, 2011 Dec 15.
Article
in English
| MEDLINE | ID: mdl-22535500
17.
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate.
Int J Radiat Oncol Biol Phys
; 110(3): 700-707, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33186617
18.
Duplicating a tandem and ovoids distribution with intensity-modulated radiotherapy: a feasibility study.
J Appl Clin Med Phys
; 8(3): 91-98, 2007 Jul 17.
Article
in English
| MEDLINE | ID: mdl-17712303
19.
The effect of positional realignment on dose delivery to the prostate and organs-at-risk for 3DCRT.
Med Dosim
; 32(1): 1-6, 2007.
Article
in English
| MEDLINE | ID: mdl-17317528
20.
Comparison of Onsite Versus Online Chart Reviews as Part of the American College of Radiation Oncology Accreditation Program.
J Oncol Pract
; 13(5): e516-e521, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28301278